Structure Therapeutics Inc. - 8-K Filing
Structure Therapeutics held its Annual General Meeting on June 17, 2026, where shareholders elected directors Ted W. Love M.D., Raymond Stevens Ph.D., and Daniel G. Welch; ratified the appointment of Ernst & Young LLP as independent auditors with 99.85% approval; and approved executive compensation via advisory vote with 94.37% support. (Items: 5.07 Submission of Matters to a Vote of Security Holders)
Tickers: $GPCR